These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23209830)

  • 21. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective Effect of Cyclo-(L-Pro-L-Phe) Isolated from the Jellyfish-Derived Fungus
    Li DD; Wang Y; Kim E; Hong J; Jung JH
    Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action.
    Dutta AK; Ghosh B; Biswas S; Reith ME
    Eur J Pharmacol; 2008 Jul; 589(1-3):73-9. PubMed ID: 18561912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexually dimorphic responses of rats to fluoxetine in the forced swimming test are unrelated to the function of the serotonin transporter in the brain.
    Domingues K; Lima FB; Linder AE; Melleu FF; Poli A; Spezia I; Suman PR; Theindl LC; Lino de Oliveira C
    Synapse; 2020 Jan; 74(1):e22130. PubMed ID: 31449695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for noncompetitive modulation of substrate-induced serotonin release.
    Rothman RB; Baumann MH; Blough BE; Jacobson AE; Rice KC; Partilla JS
    Synapse; 2010 Nov; 64(11):862-9. PubMed ID: 20842720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
    Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T; Kogen H
    Bioorg Med Chem; 2003 Oct; 11(20):4389-415. PubMed ID: 13129577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimycobacterial activity of cyclic dipeptides isolated from Bacillus sp. N strain associated with entomopathogenic nematode.
    Nishanth Kumar S; Mohandas C
    Pharm Biol; 2014 Jan; 52(1):91-6. PubMed ID: 24047443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
    Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice.
    Perez XA; Andrews AM
    Anal Chem; 2005 Feb; 77(3):818-26. PubMed ID: 15679349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent reporters of monoamine transporter distribution and function.
    Bagale SM; Brown AS; Gonzalez MM; Vitores A; Micotto TL; Kumar NS; Hentall ID; Wilson JN
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7387-91. PubMed ID: 22047697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.
    Giacobini E; Zhu X D; Williams E; Sherman KA
    Neuropharmacology; 1996 Feb; 35(2):205-11. PubMed ID: 8734490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task.
    Wong KK; Ho MT; Lin HQ; Lau KF; Rudd JA; Chung RC; Fung KP; Shaw PC; Wan DC
    Planta Med; 2010 Feb; 76(3):228-34. PubMed ID: 19774505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
    Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA, glutamate, dopamine and serotonin transporters expression on forgetting.
    Tellez R; Gómez-Viquez L; Liy-Salmeron G; Meneses A
    Neurobiol Learn Mem; 2012 Jul; 98(1):66-77. PubMed ID: 22633984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations.
    Bundgaard C; Sveigaard C; Brennum LT; Stensbøl TB
    Xenobiotica; 2012 Mar; 42(3):256-65. PubMed ID: 22017605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
    He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
    J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.